Cargando…

Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials

SUMMARY: In this meta-analysis of all Merck-conducted, placebo-controlled clinical trials of alendronate, the occurrence of AF was uncommon, with most studies reporting two or fewer events. Across all studies, no clear association between overall bisphosphonate exposure and the rate of serious or no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrett-Connor, E., Swern, A. S., Hustad, C. M., Bone, H. G., Liberman, U. A., Papapoulos, S., Wang, H., de Papp, A., Santora, A. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249176/ https://www.ncbi.nlm.nih.gov/pubmed/21369791 http://dx.doi.org/10.1007/s00198-011-1546-9

Ejemplares similares

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
por: Bone, Henry G, et al.
Publicado: (2018)

Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
por: Bone, H. G., et al.
Publicado: (2017)

Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand
por: Songpatanasilp, Thawee, et al.
Publicado: (2018)

Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
por: Bone, H. G., et al.
Publicado: (2015)

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
por: Bone, H. G., et al.
Publicado: (2014)

Nickel alendronate
por: Sikorska, Małgorzata, et al.
Publicado: (2012)

Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials
por: Li, Daobo, et al.
Publicado: (2021)

The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover: A Randomized Non-inferiority Trial
por: Hikmet, Rawan, et al.
Publicado: (2023)

Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
por: Zhang, Z. L., et al.
Publicado: (2015)

Erratum to: Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
por: Zhang, Z. L., et al.
Publicado: (2015)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Effects of alendronate for treatment of glucocorticoid-induced osteoporosis: A meta-analysis of randomized controlled trials
por: Wang, Ya-Kang, et al.
Publicado: (2018)

Possible alendronate-induced polyarticular synovitis
por: Gökkuş, K, et al.
Publicado: (2016)

Postoperative Atrial Fibrillation
por: Chelazzi, C., et al.
Publicado: (2011)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
por: Shahid, Farhan, et al.
Publicado: (2018)

Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Khabbazi, Alireza, et al.
Publicado: (2014)

Atrial Fibrillation Cycle Length and Atrial Size in Horses with and without Recurrence of Atrial Fibrillation after Electrical Cardioversion
por: De Clercq, D., et al.
Publicado: (2014)

Alendronate-associated focal segmental glomerulosclerosis
por: Prikis, Marios, et al.
Publicado: (2009)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Hybrid ablation for atrial fibrillation: A systematic review and meta-analysis
por: Varzaly, Jason A., et al.
Publicado: (2021)

Alendronic Acid as Ionic Liquid: New Perspective on Osteosarcoma
por: Teixeira, Sónia, et al.
Publicado: (2020)

Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials
por: Wang, Ya-Kang, et al.
Publicado: (2017)

Long-Term Alendronate Use Not without Consequences?
por: Somford, M. P., et al.
Publicado: (2009)

Bisphosphonates and risk of atrial fibrillation: a meta-analysis
por: Kim, Seo Young, et al.
Publicado: (2010)

Association of atrial fibrillation with diabetic nephropathy: A meta-analysis
por: Arnous, Maha M., et al.
Publicado: (2022)

Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
por: Sethi, Naqash J., et al.
Publicado: (2017)

Intraoperative Inducibility of Atrial Fibrillation Does Not Predict Early Postoperative Atrial Fibrillation
por: Lanters, Eva A. H., et al.
Publicado: (2018)

Atrial fibrillation: to map or not to map?
por: Yaksh, A., et al.
Publicado: (2013)

Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial
por: Pawade, Tania A., et al.
Publicado: (2021)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Catheter vs thoracoscopic ablation for atrial fibrillation: Meta‐analysis of randomized trials
por: Wang, Tom Kai Ming, et al.
Publicado: (2020)

The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients
por: Wu, L., et al.
Publicado: (2022)

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study
por: Lau, E. M. C., et al.
Publicado: (2020)

Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports
por: Chavez, Patricia, et al.
Publicado: (2015)

Association between alendronate and atypical femur fractures: a meta-analysis
por: Liu, Lu, et al.
Publicado: (2015)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

A randomized placebo-controlled trial with amiodarone for persistent atrial fibrillation in rheumatic mitral stenosis after successful balloon mitral valvuloplasty
por: Vilvanathan, Vinoth Kumar, et al.
Publicado: (2016)

Nonpharmacological Therapies for Atrial Fibrillation
por: Caldwell, Jane C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hf81vk838g13apnrfl0o6tlu5a